Avidian Wealth Enterprises’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Sell |
1,192
-33
| -3% | -$14.7K | 0.02% | 320 |
|
|
2025
Q1 | $594K | Buy |
1,225
+25
| +2% | +$12.1K | 0.03% | 279 |
|
|
2024
Q4 | $483K | Buy |
1,200
+58
| +5% | +$23.4K | 0.02% | 298 |
|
|
2024
Q3 | $531K | Sell |
1,142
-111
| -9% | -$51.6K | 0.02% | 287 |
|
|
2024
Q2 | $587K | Buy |
1,253
+740
| +144% | +$347K | 0.02% | 248 |
|
|
2024
Q1 | $214K | Buy |
+513
| New | +$214K | 0.01% | 407 |
|
|
2022
Q1 | – | Sell |
-985
| Closed | -$216K | – | 561 |
|
|
2021
Q4 | $216K | Buy |
+985
| New | +$216K | 0.01% | 472 |
|
|
2018
Q4 | – | Sell |
-6,108
| Closed | -$1.18M | – | 119 |
|
|
2018
Q3 | $1.18M | Buy |
6,108
+404
| +7% | +$77.9K | 0.37% | 28 |
|
|
2018
Q2 | $969K | Buy |
+5,704
| New | +$969K | 0.31% | 32 |
|